By: Guillen H.B. No. 4160
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the creation of the Alzheimer's Research Collaborative
  of Texas.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subchapter D, Chapter 102, Health and Safety
  Code, is amended by adding Section 102.157 to read as follows:
         Sec. 102.157.  OVERSIGHT COMMITTEE FOR NEURODEGENERATIVE
  DISEASES. (a) In this section:
               (1)  "Committee" means the Oversight Committee for
  Neurodegenerative Diseases.
               (2)  "Nationally designated" means a designation from
  the National Institute on Aging.
               (3)  "Research collaborative" means the Alzheimer's
  Research Collaborative of Texas.
         (b)  The Oversight Committee for Neurodegenerative Diseases
  is the governing body of the Alzheimer's Research Collaborative of
  Texas. The committee is composed of the following eight members:
               (1)  four members appointed by the lieutenant governor;
  and
               (2)  four members appointed by the speaker of the house
  of representatives.
         (c)  In making appointments to the committee, the lieutenant
  governor and the speaker of the house of representatives must each
  appoint:
               (1)  three members who are physicians or scientists
  with extensive experience in the field of Alzheimer's disease and
  neurology; and
               (2)  one member of the public.
         (d)  From each group of appointees under Subsection (c)(1),
  one appointee must represent a nationally designated Alzheimer's
  Disease Research Center and shall serve as co-chair of the
  committee.
         (e)  A member of the committee serves at the will of the
  official who appointed the member.
         (f)  The research collaborative is established to support
  Alzheimer's disease research described by Subsection (h).  The
  committee shall oversee the review processes and related procedures
  of the collaborative.
         (g)  The committee shall establish standards and hire
  personnel as necessary to ensure the proper use of funds authorized
  for Alzheimer's disease research, facilities development, and
  caregiver resources consistent with the powers and duties described
  under Section 102.051.
         (h)  The committee shall establish criteria for the research
  collaborative to support institutions of learning and advanced
  medical research facilities and collaborations in this state in all
  stages of finding the causes of Alzheimer's disease and other
  neurodegenerative diseases in humans and developing cures, from
  laboratory research to clinical trials, including programs to
  address the problem of access to advanced treatment for Alzheimer's
  disease.
         (i)  The committee shall establish criteria for prioritizing
  its review of applications for grants to:
               (1)  academic medical centers;
               (2)  medical research facilities; and
               (3)  collaborations with a nationally designated
  Alzheimer's Disease Research Center.
         SECTION 2.  This Act takes effect September 1, 2023.